SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells

Dendritic cells (DCs) are the most potent antigen-presenting cells, and their function is essential to configure adaptative immunity and avoid excessive inflammation. DCs are predicted to play a crucial role in the clinical evolution of the infection by the severe acute respiratory syndrome (SARS) c...

Full description

Bibliographic Details
Main Authors:	Dante Barreda, César Santiago, Juan R. Rodríguez, José F. Rodríguez, José M. Casasnovas, Isabel Mérida, Antonia Ávila-Flores
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Cells
Subjects:	COVID-19 ACE-2 inflammation cytokines
Online Access:	https://www.mdpi.com/2073-4409/10/12/3279

Similar Items

Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant Women
by: Xiaofang Guo, et al.
Published: (2022-04-01)

Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
by: Theoharis C. Theoharides, et al.
Published: (2023-02-01)

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
by: Marine E. Bozdaganyan, et al.
Published: (2022-01-01)

Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants
by: Deepa Raghu, et al.
Published: (2022-02-01)

The Recognition Pathway of the SARS-CoV-2 Spike Receptor-Binding Domain to Human Angiotensin-Converting Enzyme 2
by: Can Peng, et al.
Published: (2024-04-01)

Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
by: Balkrishna A, et al.
Published: (2021-03-01)

Fullerenol C60(OH)40 Nanoparticles and Ectoine Protect Human Nasal Epithelial Cells Against the Cytokine Storm After Addition of the Full-Length Spike Protein from SARS-CoV-2
by: Sosnowska M, et al.
Published: (2024-11-01)

Differential expression of biomarkers in saliva related to SARS-CoV-2 infection in patients with mild, moderate and severe COVID-19
by: Lázaro Verdiguel-Fernández, et al.
Published: (2023-09-01)

The Cholesterol-Binding Sequence in Monomeric C-Reactive Protein Binds to the SARS-CoV-2 Spike Receptor-Binding Domain and Blocks Interaction With Angiotensin-Converting Enzyme 2
by: Hai-yun Li, et al.
Published: (2022-07-01)

Multifaceted membrane binding head of the SARS-CoV-2 spike protein
by: Anh Tran, et al.
Published: (2022-01-01)

Koroner arter bypass cerrahisinde ramiprilin miyokardiyal hasar ve inflamatuvar yanıttaki etkisi üzerinde sitokin gen polimorfizmlerinin rolü
by: Meral Urhan KÜÇÜK, et al.
Published: (2017-09-01)

Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2
by: Hai-yun Li, et al.
Published: (2022-09-01)

Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition
by: Sergio Sánchez-García, et al.
Published: (2024-10-01)

A new DNA aptamer which binds to SARS-CoV-2 spike protein and reduces pro-inflammatory response
by: Woong Kim, et al.
Published: (2024-03-01)

Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
by: Weitong Yao, et al.
Published: (2023-12-01)

Enhancement of SARS-CoV-2 receptor-binding domain activity by two microbial defensins
by: Bin Gao, et al.
Published: (2023-06-01)

Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction
by: Shijulal Nelson-Sathi, et al.
Published: (2022-01-01)

The Microalgal Diatoxanthin Inflects the Cytokine Storm in SARS-CoV-2 Stimulated ACE2 Overexpressing Lung Cells
by: Clementina Sansone, et al.
Published: (2022-08-01)

Molecular docking study and mapping the binding site of some antiviral nanobodies against receptor binding domain (RBD) of SARS-COV 2
by: zahra pahlavan, et al.
Published: (2021-06-01)

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium
by: Simon D. Pouwels, et al.
Published: (2023-05-01)

Graphene Oxide Decreases Pro-Inflammatory Proteins Production in Skeletal Muscle Cells Exposed to SARS-CoV-2 Spike Protein
by: Bałaban J, et al.
Published: (2023-01-01)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
by: Abdullah Hoter, et al.
Published: (2022-05-01)

Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
by: Yixin Xie, et al.
Published: (2020-12-01)

Little Brown Bats (<i>Myotis lucifugus</i>) Support the Binding of SARS-CoV-2 Spike and Are Likely Susceptible to SARS-CoV-2 Infection
by: Shubhada K. Chothe, et al.
Published: (2023-04-01)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
by: Riadh Badraoui, et al.
Published: (2021-01-01)

Investigation of some plant stilbenoids and their fragments for the identification of inhibitors of SARS-CoV-2 viral spike/ACE2 protein binding
by: Cyril T. Namba-Nzanguim, et al.
Published: (2024-06-01)

Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells
by: K. J. Senthil Kumar, et al.
Published: (2020-06-01)

Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity
by: Ratul Chowdhury, et al.
Published: (2020-01-01)

Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity
by: Ramakrishnan Veerabathiran, et al.
Published: (2021-04-01)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
by: Thomas A. Strong, et al.
Published: (2021-12-01)

Receptor-binding domain-anchored peptides block binding of severe acute respiratory syndrome coronavirus 2 spike proteins with cell surface angiotensin-converting enzyme 2
by: Ting Wang, et al.
Published: (2022-09-01)

SARS-CoV-2 omicron spike simulations: broad antibody escape, weakened ACE2 binding, and modest furin cleavage
by: M. Zaki Jawaid, et al.
Published: (2023-10-01)

Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells
by: Rahul Dilawari, et al.
Published: (2024-02-01)

The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs
by: Hoang Oanh Nguyen, et al.
Published: (2022-01-01)

Sulfated polysaccharides act as baits to interfere with the binding of the spike protein (SARS-CoV-2) to the ACE2 receptor and can be administered through food
by: Jhonatas Rodrigues Barbosa, et al.
Published: (2023-05-01)

Exploring the Interaction between Vancomycin/Teicoplanin and Receptor Binding Domain (RBD) of SARS-CoV-2
by: Wen-Tao Tao, et al.
Published: (2021-01-01)

Binding affinity between coronavirus spike protein and human ACE2 receptor
by: Marcus Ho-Hin Shum, et al.
Published: (2024-12-01)

Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme
by: Marco Pitino, et al.
Published: (2022-12-01)

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
by: Michael I Barton, et al.
Published: (2021-08-01)

A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants
by: Ludovico Pipitò, et al.
Published: (2022-10-01)